此外，研究也證實，術前白蛋白水平低與冠狀動脈支架術後再狹窄的發生有關，

此外，研究也證實，術前白蛋白水平低與冠狀動脈支架術後再狹窄的發生有關，並增加心血管疾病的發生率和死亡率。 最近的研究報告了幾種新型生物標記物，包括治療前狹窄病變長度（SLL）和嗜中性球與白蛋白的比率，可以預測冠狀動脈、頸動脈或椎動脈支架置入術患者對再狹窄發展的病理完全反應。 然而，對於接受 PTAS 的 PIRCS 鼻咽癌患者，與 ISR 率相關的因素尚不清楚。

結果 (英文) 1:

In addition, studies have also confirmed that low preoperative albumin levels are associated with the occurrence of restenosis after coronary artery stent surgery and increase the incidence of cardiovascular disease and mortality. Recent studies report that several novel biomarkers, including pretreatment stenotic lesion length (SLL) and neutrophil-to-albumin ratio, can predict the risk of restenosis in patients undergoing coronary, carotid, or vertebral artery stenting. Development of pathological complete response. However, factors associated with ISR rates in PIRCS NPC patients undergoing PTAS are unclear.

結果 (英文) 2:

In addition, research has also confirmed that low preoperative albumin levels are associated with the occurrence of restenosis after coronary artery stenting, and increase the incidence and mortality of cardiovascular diseases. Recent studies have reported several novel biomarkers, including pre treatment stenosis lesion length (SLL) and the ratio of neutrophils to albumin, which can predict the pathological complete response of patients undergoing coronary, carotid, or vertebral artery stent implantation to the development of restenosis. However, the factors associated with ISR rate in PIRCS nasopharyngeal carcinoma patients receiving PTAS are still unclear.

結果 (英文) 3:

In addition, the study also confirmed that the low preoperative albumin level is related to the occurrence of restenosis after coronary stent implantation, and increases the incidence and mortality of cardiovascular diseases. Recent studies have reported several new biomarkers, including the lesion length (SLL) of stenosis before treatment and the ratio of neutrophil to albumin, which can predict the pathological complete response of patients undergoing coronary artery, carotid artery or vertebral artery stent implantation to the development of restenosis. However, the factors related to ISR rate in patients with PIRCS nasopharyngeal carcinoma receiving PTAS are not clear.